by Jordana Choucair | Feb 8, 2022 | Opioid/Substance Use Disorders
Texas reached a $225 million settlement with Teva Pharmaceuticals to resolve claims the drugmaker fueled an opioid epidemic in Texas by improperly marketing addictive pain medications. The settlement will provide needed resources to local law enforcement and the...
by Jordana Choucair | Feb 3, 2022 | Opioid/Substance Use Disorders
A study published in the Lancet found that the opioid epidemic could claim another 1.2 million lives in North America over the next seven years. The researchers warned that the epidemic may widen globally without stricter regulation to stop companies from exporting...
by Jordana Choucair | Feb 2, 2022 | Opioid/Substance Use Disorders
The Department of Justice secured more than $5 billion related to fraud and false claims in the health care sector in the year ending in September 2021, making up nearly 90 percent of the agency’s settlement proceeds for False Claims Act violations. The largest...
by Jordana Choucair | Feb 2, 2022 | Opioid/Substance Use Disorders
A group of 574 Native American tribes reached a tentative $590 million settlement with Johnson & Johnson and the country’s three largest drug distributors — McKesson Corp., Cardinal Health Inc., and AmerisourceBergen Corp. — over their role in the opioid...
by Jordana Choucair | Feb 1, 2022 | Opioid/Substance Use Disorders
Adolescents and young adults lost an estimated 1.2 million years of life due to unintentional drug overdoses over between 2015 and 2019, according to a research letter published in JAMA. About 3,300 adolescents ages 10–19 years old died of an unintentional drug...
by Jordana Choucair | Jan 26, 2022 | Opioid/Substance Use Disorders
Rhode Island Attorney General Peter Neronha announced the state reached a settlement with an opioid manufacturer and opioid distributors. The settlement includes $21.1 million from Johnson & Johnson and an additional $90.8 million in total from AmerisourceBergen,...
Recent Comments